RxDoctor Payments Data

Kimberly Ndahayo

Adult Health · Aurora, CONPI 1699315374

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,533 of the $5,455 with a category attached, or 64.8%. 8 manufacturers reported payments, led by Livanova USA, Inc. at 44.4% of the total. Among adult health clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,455in general payments, 2019–2025

Across 58 payments — averaging $94.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$2K
  • SK Life Science, Inc.$1K
  • UCB, Inc.$658
  • Jazz Pharmaceuticals Inc.$647
  • Neurelis, Inc.$402
  • Eisai Inc.$114
  • plus $57 from 2 others

What the payments were for

  • Travel & lodging$1,88935%
  • Food & beverage$3,53365%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,455 in reported general payments places this provider in the 95th percentile of 430 adult health providers in Colorado.

See all adult health providers in Colorado

Medicare billing

Part B allowed, 2024
$10,767
Medicare patients
56
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XcopriCenobamate119$172,649
EpidiolexCannabidiol (Cbd)13$116,604
KeppraLevetiracetam19$54,049
Oxtellar XrOxcarbazepine45$51,106
BriviactBrivaracetam14$32,604
LamictalLamotrigine26$24,103
NayzilamMidazolam16$13,890
Clobazam90$7,647
Lamotrigine ErLamotrigine29$6,604
Carbamazepine ErCarbamazepine39$6,384
Lacosamide80$5,201
Levetiracetam110$4,700
CarbatrolCarbamazepine27$4,126
Lamotrigine136$3,205
Topiramate58$2,716

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
SK Life Science, Inc.Xcopri$1,155$172,649119 claims
UCB, Inc.Briviact, Nayzilam$658$46,49430 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 430 adult health providers in Colorado.

Other adult health in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →